全文获取类型
收费全文 | 49937篇 |
免费 | 3270篇 |
国内免费 | 909篇 |
专业分类
耳鼻咽喉 | 287篇 |
儿科学 | 2082篇 |
妇产科学 | 1357篇 |
基础医学 | 6526篇 |
口腔科学 | 1338篇 |
临床医学 | 3485篇 |
内科学 | 9790篇 |
皮肤病学 | 765篇 |
神经病学 | 3798篇 |
特种医学 | 2118篇 |
外国民族医学 | 6篇 |
外科学 | 6421篇 |
综合类 | 3473篇 |
现状与发展 | 3篇 |
预防医学 | 3899篇 |
眼科学 | 479篇 |
药学 | 4970篇 |
30篇 | |
中国医学 | 984篇 |
肿瘤学 | 2305篇 |
出版年
2023年 | 654篇 |
2022年 | 1544篇 |
2021年 | 2053篇 |
2020年 | 1672篇 |
2019年 | 2655篇 |
2018年 | 2640篇 |
2017年 | 1775篇 |
2016年 | 1379篇 |
2015年 | 1419篇 |
2014年 | 2472篇 |
2013年 | 2535篇 |
2012年 | 1794篇 |
2011年 | 1928篇 |
2010年 | 1571篇 |
2009年 | 1697篇 |
2008年 | 1546篇 |
2007年 | 1463篇 |
2006年 | 1366篇 |
2005年 | 1125篇 |
2004年 | 1003篇 |
2003年 | 972篇 |
2002年 | 729篇 |
2001年 | 693篇 |
2000年 | 618篇 |
1999年 | 579篇 |
1998年 | 475篇 |
1997年 | 428篇 |
1996年 | 364篇 |
1995年 | 319篇 |
1994年 | 281篇 |
1993年 | 221篇 |
1992年 | 201篇 |
1991年 | 207篇 |
1990年 | 181篇 |
1989年 | 168篇 |
1988年 | 170篇 |
1987年 | 138篇 |
1985年 | 1102篇 |
1984年 | 1905篇 |
1983年 | 1172篇 |
1982年 | 1323篇 |
1981年 | 1247篇 |
1980年 | 1031篇 |
1979年 | 937篇 |
1978年 | 833篇 |
1977年 | 719篇 |
1976年 | 811篇 |
1975年 | 583篇 |
1974年 | 517篇 |
1973年 | 579篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Simon Vinitski Carlos Gonzalez Feroze Mohamed Tad Iwanaga Robert L. Knobler Kamil Khalili John Mack 《Magnetic resonance in medicine》1997,37(3):457-469
Our aim was to develop an accurate multispectral tissue segmentation method based on 3D feature maps. We utilized proton density (PD), T2-weighted fast spin-echo (FSE), and T1-weighted spin-echo images as inputs for segmentation. Phantom constructs, cadaver brains, an animal brain tumor model and both normal human brains and those from patients with either multiple sclerosis (MS) or primary brain tumors were analyzed with this technique. Initially, misregistration, RF inhomogeneity and image noise problems were addressed. Next, a qualified observer identified samples representing the tissues of interest. Finally, k-nearest neighbor algorithm (k-NN) was utilized to create a stack of color-coded segmented images. The inclusion of T1 based images, as a third input, produced significant improvement in the delineation of tissues. In MS, our 3D technique was found to be far superior to that based on any combination of 2D feature maps (P < 0.001). We identified at least two distinctly different classes of lesions within the same MS plaque, representing different stages of the disease process. Further, we obtained the regional distribution of MS lesion burden and followed its changes over time. Neuropsychological aberrations were the clinical counterpart of the structural changes detected in segmentation. We could also delineate the margins of benign brain tumors. In malignant tumors, up to four abnormal tissues were identified: 1) a solid tumor core, 2) a cystic component, 3) edema in the white matter, and 4) areas of necrosis and hemorrhage. Subsequent neurosurgical exploration confirmed the distribution of tissues as predicted by this analysis. 相似文献
42.
In this study, the behavioural response to dopamine D1-like receptor agonists (SKF 38393, SKF 81297 and SKF 77434) and D2-like receptor agonists (quinpirole and RU 24213), administered alone and in combination to rats treated repeatedly with electroconvulsive
shock (five ECS over 10 days) or sham, was tested. Agonist-induced behaviour was monitored by automated activity meters and
direct observation using a checklist scoring method. Repeated ECS (compared to sham controls) had no significant effect on
the behavioural response to SKF 38393 (7.5 mg/kg SC), SKF 81297 (0.2 mg/kg SC), SKF 77434 (0.1 mg/kg SC), quinpirole (0.1
and 0.25 mg/kg SC) or RU 24213 (0.3 mg/kg SC), when administered alone. In contrast, repeated ECS markedly increased locomotion
(activity counts and scores) induced by the non-selective dopamine agonist apomorphine (0.5 mg/kg SC) and by co-administration
of a D1-like agonist plus a D2-like agonist [SKF 38393 (7.5 mg/kg SC) plus quinpirole (0.25 mg/kg SC), SKF 81297 (0.2 mg/kg SC) plus quinpirole (0.1 mg/kg
SC), and SKF 77434 (0.1 mg/ kg SC) plus RU 24213 (0.3 mg/kg SC)]. This ECS-induced enhancement of dopamine-mediated behaviour
was observed for up to 3 weeks after cessation of ECS treatment. In addition, ECS also enhanced the locomotor response to
intra-accumbens SKF 38393 plus quinpirole (0.4 and 1.0 μg/side, respectively). These results provide evidence that the enhancement
of dopamine function by repeated ECS requires concomitant stimulation of both D1-like and D2-like receptors, and that this effect is long-lasting.
Received: 24 January 1997 /Final version: 5 March 1997 相似文献
43.
Adorján F. Kovács Waleed Megahed Michael Scholz Robert Sader 《Mund-, Kiefer- und Gesichtschirurgie》2007,11(5):267-283
PURPOSE: The development of overall survival of a DOSAK (German-Austrian-Swiss Cooperative Group on tumours of the maxillofacial region) clinic's overall population comprising a time period of more than 20 years (1983-2004) should be assessed. At a cutoff date (January 1st, 1997), a change from a primarily surgically based to a consequent multi-modality treatment regimen was implemented. The periods of time before and after that change should be compared. METHODS AND PATIENTS: The data of the DOSAK registry entries on 1038 patients suffering from primary untreated oral and oropharyngeal carcinomas were updated with respect to follow-up and mortality data to achieve a 100% quality of follow-up. The end point (death) was reached in 67% of the overall population. Statistical analysis was carried out by the Trium Analysis Online corporation, Munich. RESULTS: The portion of female and older tumor patients increased, more than half of all tumor patients were clearly in stage IV of the disease at first referral. The portion of patients operated on persisted approximately (80%), the portion of additional treatment modalities could be increased considerably. The fact of a bony infiltration by the tumor and the operability remained highly significantly relevant for survival in multivariate analysis, despite of multi-modality treatment. The survival rate of the patients remained significantly dependent on the clinical stage of the disease in multivariate analysis but could be improved by 10% in the clinical stages II and III and in the patients who could not be operated on. All in all, the cutoff date was statistically relevant for survival in multivariate analysis, i.[Symbol: see text]e. the change in the treatment regimen had a verifiable positive effect on the survival of a unicentric overall population. CONCLUSION: Survival improvement in an overall population via change in treatment strategy is possible in relatively short time; the clinical stages II and III and the non-operable patients have the greatest benefit from a multi-modality treatment. 相似文献
44.
D4S1647、D6S2414基因座在中国汉族、蒙古族、藏族的遗传多态性 总被引:3,自引:3,他引:0
目的 调查D4S1647、D6S2414基因座在中国汉族、蒙古族、藏族群体中的遗传分布规律。方法 采集308份血及唾液标本应用PCR技术,扩增产物用非变性聚丙酰胺凝胶电泳分离,银染显色分析。结果 两位点各群体基因型频率分布均符合Hardy-Weinberg平衡,每一位点等位基因频率分布在各群体间无显著差异;通过对10个汉族家系的遗传模式分析,证实了两位点等位基因传递遵循孟德尔遗传规律。结论 D4S1647、D6S2414基因座在中国汉族,蒙古族,藏族群体均具有高度遗传多态性。 相似文献
45.
利培酮治疗与细胞色素P4502D6/C188T酶基因多态性的关联分析 总被引:2,自引:0,他引:2
目的 研究利培酮临床效应的个体差异与其代谢酶细胞色素P4 5 0 2D6 (cytochromeP4 5 02D6 ,CYP2D6 )酶基因多态性的相关性。方法 对 88例符合CCMD 3精神分裂症诊断标准的患者和 96例健康对照者作病例 -对照分析。精神分裂症患者给予利培酮治疗 8周 ,用阳性和阴性症状量表 (posi tiveandnegativesymptomscale ,PANSS)评分评价利培酮疗效。采用聚合酶链反应扩增及限制性片段长度多态性 (PCR RFLP)技术对CYP2D6exonⅠ的C188T位点突变进行检测 ,分析利培酮临床效应与其主要代谢酶CYP2D6 /C188T酶基因多态性的相关性。结果 中国上海地区人群的CYP2D6 /C188T突变率(弱代谢型 )为 36 .3% ,病例组和正常对照组间基因型频率总体分布比较无显著差异 (χ2 =1.15 ,df=2 ,P >0 .0 5 ) ,两组间的等位基因频率之间比较也无显著性差异 (χ2 =0 .78,df=1,P >0 .0 5 )。进行性别及有否家族史分组后分析 ,亦无差异存在 ,且CYP2D6 /C188T突变与利培酮临床效应之间并无相关性 (χ2 =1.12 ,df=2 ;χ2 =0 .0 3,df=1,P >0 .0 5 )。结论 未发现中国人CYP2D6 /C188T多态性与利培酮临床效应的个体差异有相关性。 相似文献
46.
Twenty-six patients diagnosed as chronic schizophrenics were given injections of zuclopenthixol decanoate (cis(Z)-clopenthixol decanoate) 200 mg every 3 weeks for at least 6 months. Before treatment and on each day of injection the
patients' mental state was assessed by Brief Psychiatric Rating Scale (BPRS), 18 items. A registration of side effects and
basal laboratory data was also performed. Blood samples were drawn on each day of injection before injection and 3–7 days
after injection (time of maximum concentration). Neuroleptic activity, which was considered equivalent to the concentration
of zuclopenthixol, was determined in serum by radio-receptor assay (RRA). Based on amelioration scores ≥50% on the BPRS, 15
patients were characterized as responders and 11 as non-responders. The responder group showed a statistically significant
reduction in BPRS score, whereas this was not the case for the non-responders. Apart from a few patients, the serum concentrations
showed a low intra-individual variation, but a relatively high inter-individual variation. The responder group had a significantly
higher mean preinjection concentration than the non-responder group, whereas no significant difference was found in day 3–7
concentrations. The fluctuation of the serum concentration expressed as the ratio between maximum (days 3–7) and minimum (pre-inj.)
was found to be significantly lower for responders than for non-responders. Thus although the present study did not demonstrate
a clear relationship between serum level and clinical effect, it indicates that the best antipsychotic effect is obtained
with a serum concentration which fluctuates only slightly (the ratio max/min concentration not exceeding 2.1). 相似文献
47.
48.
C.K. Biswas J.M. Ramos D.N.S. Kerr 《Clinica chimica acta; international journal of clinical chemistry》1981,116(3):343-347
The effect of heparin on plasma ionised calcium was studied by adding it in increasing amounts to whole blood from 10 normal subjects. There was no significant change in ionised calcium from the addition of 1 U/ml but a significant fall of 0.02 mmol/1 when 2 U/ml were added and a progressive further fall with increasing concentrations. Heparin from three different manufacturers produced similar results. The effect of heparinisation in vivo was studied during regular haemodialysis on 10 patients with chronic renal failure. Following intravenous injection of 10000 U of heparin there was a consistent and significant fall averaging 0.03 mmol/l. 相似文献
49.
Vitamin D metabolites can prevent estrogen depletion-induced bone loss in ovariectomized (OVX) rats. Our aim was to compare
the bone-protective effects of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), 1α,25-dihydroxyvitamin D2 (1,25(OH)2D2), 1α-hydroxyvitamin D3 (1α(OH)D3), and 1α-hydroxyvitamin D2 (1α(OH)D2) in OVX rats. 1α(OH)D3 and 1α(OH)D2 are thought to be activated in the liver to form 1,25(OH)2D3 and 1,25(OH)2D2, respectively. Forty-four 12-week-old female Fischer-344 rats were either OVX or sham-operated (SHAM). Groups of OVX rats
(n = 7 each) received vehicle alone, 1,25(OH)2D3, 1,25(OH)2D2, 1α(OH)D3, or 1α(OH)D2, starting 2 weeks after surgery. All vitamin D metabolites were administered orally at a dose of 15 ng/day/rat. Urine and
blood samples were collected 6, 9, 12, and 16 weeks after surgery. Serum samples were analyzed for total calcium and phosphate.
Calcium, phosphate, creatinine, and free collagen cross-links (ELISA) were determined in urine. After tetracycline double
labeling, the rats were sacrificed 16 weeks postsurgery, and the proximal tibiae and the first lumbar vertebrae were processed
undecalcified for static and dynamic bone histomorphometry. 1,25(OH)2D3 and, to a slightly lesser extent, 1,25(OH)2D2 elevated vertebral cancellous bone mass in OVX rats to a level beyond that observed in SHAM animals, and both compounds increased
serum calcium and urinary calcium excretion to similar extents. 1α(OH)D3 and 1α(OH)D2 resulted in a 64% and 84%, respectively, inhibition of ovariectomy-induced vertebral cancellous bone loss. In the proximal
tibial metaphysis, all vitamin D metabolites tested could only partially prevent post-OVX trabecular bone loss, with a tendency
for 1α(OH)D3 to be the least active compound. The effects of 1α(OH)D3 and 1α(OH)D2 on calcium homeostasis differed markedly, however. The mean increase in urinary calcium excretion over the whole experiment
was fivefold for 1α(OH)D3, whereas the corresponding increase for 1α(OH)D2 was only twofold. We conclude that, compared with 1α(OH)D3, 1α(OH)D2 combined at least equal or higher bone-protective activity in OVX rats with distinctly less pronounced effects on calcium
homeostasis. This effect was not due to a differential action of the corresponding main activation products, 1,25(OH)2D3 and 1,25(OH)2D2.
Received: 2 May 1996 / Accepted: 18 October 1996 相似文献
50.
Dr. Seema A. Khan MD Nick J. Gonchoroff DrPH Linda E. Miller PhD 《Annals of surgical oncology》1997,4(6):462-469
Background: Many studies have addressed the effect of the timing of surgery for breast cancer relative to menstrual cycle phase, with
conflicting results. Explanations for the possibility that survival could be altered by the appropriate timing of breast cancer
surgery in humans remain speculative.
Methods: We examined the expression of three estrogen related proteins (c-erbB-2, cathepsin D, pS2) in the breast tumors from 69 premenopausal women sampled in different phases of the menstrual cycle.
Data on S-phase fraction and hormone receptor expression were also analyzed. Immunohistochemical assays were used to measure
the proteins of interest. S-phase fraction was determined by flow cytometry. Analyses were performed based on fraction of
cells staining positive for the protein, density of stain, and a histoscore that combined both fraction of positive cells
and density.
Results: We found no differences in c-erbB-2, cathepsin D, hormone receptor, or S-phase levels in tumors sampled in the follicular versus luteal phase, or perimenstrual
versus periovulatory phase. The exception was pS2, which was expressed at greater levels during the luteal than during the
follicular phase of the cycle (p<0.01); but there was no difference in pS2 expression when the patients were classified as
periovulatory versus perimenstrual.
Conclusions: Our findings do not support a variation in c-erbB-2, cathepsin D, S-phase fraction, or receptor expression as an explanation for the differences in breast cancer prognosis
when surgery is timed by menstrual cycle phase. The finding that pS2 (an indicator of hormone sensitivity, and possibly better
prognosis) is expressed at higher levels in tumor samples during the luteal phase suggests that the biologic profile of breast
tumors may vary with the menstrual cycle and that these variations deserve further study. 相似文献